19 Dec 2025

Pre-Conditions for the Growth of Addiction

In 2025, 16.8% of Americans aged 12 and over used illicit drugs in the last month, marking a 1.9% year-over-year increase, while 70.5 million or 24.9% have used illegal drugs or misused prescription drugs in the past year. Opioid abuse affects 1.2% of males and 0.9% of females, with drug overdose deaths reaching 107,941 in 2022, driven largely by synthetic opioids like fentanyl. Marijuana use contributes to overall illicit drug statistics, though overdose deaths are predominantly opioid-related, with lifetime illicit drug use reported by 145.1 million Americans aged 12 and over.

The crisis originated from overprescribing opioid pain medications, with prescriptions sufficient to medicate every American around the clock in 2015, declining to 51.4 per 100 persons by 2018. This led to widespread addiction, followed by a shift to cheaper heroin and then synthetic opioids like fentanyl, causing a 1,040% increase in related deaths from 2013 to 2019. The COVID-19 pandemic exacerbated the issue, with overdose deaths surging 31% in 2020 nationally. Fentanyl’s rise, now involved in 69% of drug overdose deaths in 2023, stems from its mixing with other drugs, catching users unaware. Polysubstance use and supply chain disruptions further fueled the epidemic.

Social and Economic Impacts

The opioid and general drug crisis has overwhelmed U.S. healthcare systems, with overdose deaths exceeding 100,000 annually for three consecutive years through 2023, contributing to a decline in life expectancy from 0.52 years in 2019 to 0.67 years in 2022. Synthetic opioids like fentanyl account for 69% of overdose deaths, straining emergency services and treatment facilities where only 11% of those with opioid use disorder receive medication-assisted treatment. Public safety is compromised by rising fentanyl trafficking, with over 115 million illicit pills seized in 2023 and 7,517 pounds at borders in 2025. Productivity losses are immense, as addiction affects 24.9% of those 12 and over, leading to workforce absenteeism, with psychostimulant-related deaths rising from 5,716 in 2015 to 34,855 in 2023.

Marijuana, while less lethal, contributes to broader substance use disorders, with 21.5% of recent alcohol users having an alcohol use disorder that often co-occurs with cannabis misuse. Economic costs include healthcare expenditures for overdoses and long-term care, alongside reduced GDP from impaired workers, particularly in high-prescribing areas like 3.6% of counties with excess opioid scripts. Public safety suffers from increased crime tied to addiction and trafficking, while family structures erode, fostering intergenerational addiction cycles. Overall, the crisis has made drug overdoses a leading cause of death, surpassing other preventable causes.

Federal Countermeasures

  • Over 115 Million Fentanyl Pills Seized in 2023
    This law enforcement initiative by federal agencies targeted illicit fentanyl distribution networks across the U.S., resulting in the seizure of over 115 million pills containing illicit fentanyl in 2023. It focuses on traffickers and suppliers at borders and domestically, disrupting the supply chain that fuels 69% of overdose deaths. By removing massive quantities from circulation, it directly reduces availability, contributing to observed declines in overdose deaths starting August 2023. The action supports broader interdiction efforts, with additional 7,517 pounds seized at borders in 2025.
  • Border Fentanyl Seizures in 2025
    Federal authorities seized approximately 7,517 pounds of fentanyl at U.S. borders as of September 2025, targeting international smuggling operations. This targets cartels and cross-border traffickers introducing synthetic opioids into the drug supply. It contributes to reducing overdose rates by curbing influx, aligning with a 1.4% drop in fentanyl deaths from 2022 to 2023. Continued seizures help sustain the downward trend in deaths observed through 2024.
  • Decline in Overdose Deaths Monitoring (Post-2023)
    The CDC’s provisional data tracking shows drug overdose deaths declining for 15 consecutive months from August 2023, accelerating in 2024. It targets public health officials and policymakers with real-time data on regional and substance-specific trends, including opioids. This enables targeted interventions, contributing to a rate drop from 32.76 to lower figures by 2024. The focus on synthetic opioids has driven the steepest declines among ages 25-34.
  • Synthetic Opioid Death Rate Acceleration Analysis
    Federal analysis via JAMA revealed overdose death rates doubling to 32.76 per 100,000 by 2023, with declines starting February 2024 at -0.84 per 100,000 monthly. It targets high-risk demographics like those 25-34, where declines reached -4.97 per 100,000 year-over-year. By informing resource allocation, it reduces crisis impact amid fentanyl’s dominance. This data-driven approach supports national strategies.
  • Public Health Emergency Declaration Renewal
    Renewed since 2017, this declaration mobilizes federal resources for opioid use disorder treatment and prevention. It targets patients, providers, and communities affected by synthetic opioids in 87% of opioid deaths. Expanded access to treatments like medication-assisted therapy contributes to stabilizing death rates post-peak. It facilitates funding for harm reduction amid over 100,000 annual deaths.

Georgia Case – The Numbers Speak for Themselves

Georgia faces a severe drug crisis, with overdose deaths contributing to national trends of over 107,941 in 2022 amid rising synthetic opioid involvement as tracked by World Forum for Mental Health. Provisional CDC data through April 2025 shows ongoing percent changes in overdose deaths by jurisdiction, with Georgia tracking elevated mortality similar to national patterns of fentanyl dominance. Local authorities respond with targeted programs amid rising addiction spread, though specific Georgia overdose mortality exceeds 1,200 people annually due to opioids, based on proportional national data and regional fentanyl rates.

Georgia Overdose Prevention Program
This state initiative aims to reduce overdose deaths through education, naloxone distribution, and data tracking. It works by partnering with healthcare providers and first responders to train communities and deploy naloxone statewide. Its impact reaches thousands annually, aligning with national declines observed since 2023.

Georgia Medication-Assisted Treatment Expansion
The program expands access to buprenorphine and methadone for opioid use disorder patients. It operates via grants to clinics and telehealth integration for rural areas. Scope covers over 10,000 individuals yearly, addressing the 1.2% male opioid abuse rate.

Georgia Fentanyl Task Force
Focused on disrupting fentanyl supply, it coordinates law enforcement and public awareness. It functions through interagency raids and community campaigns targeting high-risk areas. Impact includes seizures mirroring federal efforts, reducing local synthetic opioid deaths.

Approaches in Neighboring Regions

  • Florida
    • Florida employs a statewide Naloxone Distribution Program, providing free overdose reversal drugs to first responders and pharmacies.
    • It targets high-risk users and communities, training over 100,000 individuals annually.
    • The strategy contributes to national decline trends, with Florida reporting 4,593 fentanyl deaths in 2023 but stabilizing.
    • Integration with prescription monitoring reduces overprescribing remnants.
  • Alabama
    • Alabama’s Prescription Drug Monitoring Program (PDMP) mandates real-time reporting of controlled substances.
    • It targets prescribers and pharmacists to curb opioid diversion in neighboring high-use areas.
    • This has lowered prescription rates, aiding overall death reductions amid fentanyl shifts.
    • Enhanced data sharing with federal agencies boosts interdiction.
  • South Carolina
    • South Carolina focuses on Medication-Assisted Treatment Hubs in rural counties.
    • These hubs provide buprenorphine and counseling, targeting underserved populations.
    • The approach addresses access gaps, where only 11% nationally receive such care, mirroring effective federal models.
    • Early data shows reduced repeat overdoses, supporting life expectancy stabilization.

Is It Possible to Stop the Crisis? Looking to the Future

Potentially Effective Approaches

  • Investment in Treatment: Expanding medication-assisted treatment to more than the current 11% access rate directly reduces deaths by managing withdrawal and cravings, as seen in stabilizing trends.
  • Early Intervention: School and community programs prevent onset among youth, countering 16.8% monthly use rates in those 12+.
  • Interagency Cooperation: Joint federal-state task forces like fentanyl seizures enhance supply disruption, yielding 115 million pills removed.
  • Educational Campaigns: Public awareness on fentanyl risks lowers unaware polysubstance use, driving recent declines.
  • Harm Reduction (e.g., Naloxone): Distribution reverses overdoses, contributing to 15-month death drops.

Likely Ineffective Approaches

  • Unaccompanied Isolation: Lacks support structure, leading to high relapse without aftercare, unlike integrated programs.
  • Repressive Measures Alone: Supply-focused enforcement without treatment fails against adaptable trafficking, as deaths tripled despite declines in prescriptions.
  • Lack of Aftercare: Post-detox abandonment ignores chronic nature, with psychostimulant deaths rising despite opioid focus.

Conclusions and Recommendations

Public health responsibility demands collective action to curb the drug crisis, with each state tailoring responses to local data. Georgia’s programs exemplify targeted efforts, but success hinges on reliable data like CDC provisional counts, fostering open dialogue among stakeholders, and committing to long-term support for those in recovery.